We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+14.59%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$416M
AUM Growth
+$5.73M
Cap. Flow
-$28.5M
Cap. Flow %
-6.86%
Top 10 Hldgs %
18.98%
Holding
147
New
30
Increased
29
Reduced
49
Closed
32

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$5.71M
2
AVAV icon
AeroVironment
AVAV
+$4.55M
3
ULS icon
UL Solutions
ULS
+$4.3M
4
PCRX icon
Pacira BioSciences
PCRX
+$3.95M
5
FN icon
Fabrinet
FN
+$3.91M

Top Sells

Rank Stock Value
1
CNM icon
Core & Main
CNM
+$9.04M
2
MOD icon
Modine Manufacturing
MOD
+$8.11M
3
NTNX icon
Nutanix
NTNX
+$6.08M
4
FROG icon
JFrog
FROG
+$5.32M
5
KNSL icon
Kinsale Capital Group
KNSL
+$4.96M

Sector Composition

Rank Sector Weight
1 Technology 26.49%
2 Industrials 26.26%
3 Healthcare 20.82%
4 Consumer Discretionary 13.64%
5 Consumer Staples 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELF icon
51
e.l.f. Beauty
ELF
$5.18B
$3.96M 0.95%
18,773
-15,575
-45% -$2.77M
NARI
52
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.77M 0.91%
+78,200
New +$3.47M
MGNI icon
53
Magnite
MGNI
$2.99B
$3.76M 0.9%
282,845
-2,085
-0.7% -$22.8K
SKWD icon
54
Skyward Specialty Insurance
SKWD
$2.5B
$3.75M 0.9%
103,645
-11,715
-10% -$425K
DYN icon
55
Dyne Therapeutics
DYN
$4.85B
$3.75M 0.9%
106,140
+19,530
+23% +$568K
CRNX icon
56
Crinetics Pharmaceuticals
CRNX
$8.9B
$3.73M 0.9%
83,380
+14,155
+20% +$654K
ROAD icon
57
Construction Partners
ROAD
$6.03B
$3.65M 0.88%
66,095
-1,030
-2% -$57K
MTZ icon
58
MasTec
MTZ
$21.8B
$3.51M 0.84%
+32,785
New +$3.31M
BRBR icon
59
BellRing Brands
BRBR
$1.48B
$3.48M 0.84%
60,935
-2,575
-4% -$147K
ONON icon
60
On Holding
ONON
$12.5B
$3.46M 0.83%
89,230
+48,880
+121% +$1.79M
KNF icon
61
Knife River
KNF
$3.94B
$3.28M 0.79%
46,755
-26,085
-36% -$1.95M
ANIP icon
62
ANI Pharmaceuticals
ANIP
$1.8B
$3.25M 0.78%
51,105
+19,020
+59% +$1.23M
KEX icon
63
Kirby Corp
KEX
$7.08B
$3.22M 0.77%
+26,875
New +$3M
ONT
64
Onterris Inc
ONT
$826M
$3.05M 0.73%
68,460
+12,960
+23% +$583K
ALKT icon
65
Alkami Technology
ALKT
$2.02B
$3.05M 0.73%
107,065
-27,890
-21% -$720K
CDRE icon
66
Cadre Holdings
CDRE
$1.32B
$3.05M 0.73%
90,780
-55,135
-38% -$1.82M
VRNS icon
67
Varonis Systems
VRNS
$4.98B
$3.05M 0.73%
63,485
-24,865
-28% -$1.1M
STRL icon
68
Sterling Infrastructure
STRL
$16.6B
$3.04M 0.73%
+25,670
New +$2.93M
NXT icon
69
Nextpower Inc
NXT
$14.9B
$2.97M 0.71%
63,300
-2,000
-3% -$99.5K
HQY icon
70
HealthEquity
HQY
$8.78B
$2.88M 0.69%
33,410
-24,175
-42% -$1.95M
LUCK
71
Lucky Strike Entertainment
LUCK
$929M
$2.65M 0.64%
+182,750
New +$2.3M
EPAC icon
72
Enerpac Tool Group
EPAC
$1.9B
$2.6M 0.62%
68,090
+21,985
+48% +$815K
GWRE icon
73
Guidewire Software
GWRE
$13.3B
$2.18M 0.52%
+15,835
New +$1.91M
VKTX icon
74
Viking Therapeutics
VKTX
$3.84B
$2.15M 0.52%
40,595
-13,595
-25% -$891K
CYTK icon
75
Cytokinetics
CYTK
$10.7B
$2.12M 0.51%
39,155
+21,350
+120% +$1.29M

Similar funds

Lisanti Capital Growth's Q2 2024 Portfolio in Review

As of Q2 2024, Lisanti Capital Growth held 147 positions worth $416M, up 1.4% from $410M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $28.5M in Q2 2024, closing 32 positions and reducing 49 holdings. Its most notable exit was Core & Main, an estimated $9.04M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Lantheus worth $6.25M.

  • Lisanti Capital Growth's largest Q2 2024 buy was Lantheus: 77,875 shares worth $6.25M.
  • Lisanti Capital Growth added most to Commault Systems in Q2 2024, an estimated $3.17M increase.
  • Lisanti Capital Growth's biggest Q2 2024 reduction was Modine Manufacturing, cutting an estimated $8.11M.
  • Lisanti Capital Growth fully exited Core & Main in Q2 2024, selling an estimated $9.04M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $416M portfolio in Q2 2024.
  • Lisanti Capital Growth opened 30 new positions and closed 32 in Q2 2024.
  • Lisanti Capital Growth's portfolio value rose 1.4% quarter-over-quarter to $416M.

Based on Lisanti Capital Growth's 13F filing for Q2 2024, filed 1 Aug 2024.